OK
The material selection platform
Coatings Ingredients
The material selection platform
Coatings Ingredients
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

EBECRYL® TMPTMA

Technical Datasheet | Supplied by allnex
EBECRYL® TMPTMA by allnex is a crosslinking agent for the free radical polymerization systems. It is a trifunctional monomer, trimethylolpropane trimethacrylate which polymerizes when exposed to sources of free radicals. It is compatible with a wide range of acrylated- and methacrylated resins. It is characterized by good hardness, fast curing, high cross-liking density and good heat- & chemical resistance. It is designed for coating applications in outdoor and waterproofing systems. The shelf life of EBECRYL® TMPTMA is 2 years.
Product Type
Crosslinking / Coupling / Curing Agents
Chemical Composition
Trimethylolpropane trimethacrylate
CAS Number
3290-92-4
Physical Form
Liquid
Appearance
Clear
Product Status
COMMERCIAL
Geographical Availability
Africa, Asia / Pacific, Central and Eastern Europe, Middle East and Central Asia, North America, South and Central America, Western Europe
Applications/ Recommended for
Coatings

EBECRYL® TMPTMA Properties

Property

Value & Unit
Test Condition
Test Method
Color, APHA
< 100
Purity
90 %
(Gas Chromatography)
MeHQ Stabilizer
100 - 300 ppm

Compatiblity with other products

Find products that are predicted to be compatible with EBECRYL® TMPTMA.

This list of compatible products is generated out of estimated HSP values. A practical determination of these HSP values would provide higher certainty.
Learn more about Hansen Solubility Parameters (HSP) and their use in predictive formulation.

Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 78687 Coatings Ingredients,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top